Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction
Circulation-cardiovascular Quality and Outcomes(2021)
Key words
drug costs,drug utilization,heart failure,insurance,Medicare,prior authorization,valsartan
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined